These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 21513492)
1. Oxidative stress and endothelial function: therapeutic interventions. Tousoulis D; Briasoulis A; Papageorgiou N; Tsioufis C; Tsiamis E; Toutouzas K; Stefanadis C Recent Pat Cardiovasc Drug Discov; 2011 May; 6(2):103-14. PubMed ID: 21513492 [TBL] [Abstract][Full Text] [Related]
2. Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis. Förstermann U; Xia N; Li H Circ Res; 2017 Feb; 120(4):713-735. PubMed ID: 28209797 [TBL] [Abstract][Full Text] [Related]
3. Antioxidant treatment and endothelial dysfunction: is it time for flavonoids? Papageorgiou N; Tousoulis D; Katsargyris A; Charakida M; Androulakis E; Siasos G; Tentolouris C; Stefanadis C Recent Pat Cardiovasc Drug Discov; 2013 Aug; 8(2):81-92. PubMed ID: 23952809 [TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician. Montezano AC; Touyz RM Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098 [TBL] [Abstract][Full Text] [Related]
6. Oxidative stress, endothelial dysfunction and atherosclerosis. Victor VM; Rocha M; Solá E; Bañuls C; Garcia-Malpartida K; Hernández-Mijares A Curr Pharm Des; 2009; 15(26):2988-3002. PubMed ID: 19754375 [TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Cai H; Harrison DG Circ Res; 2000 Nov; 87(10):840-4. PubMed ID: 11073878 [TBL] [Abstract][Full Text] [Related]
8. Is oxidative stress a therapeutic target in cardiovascular disease? Münzel T; Gori T; Bruno RM; Taddei S Eur Heart J; 2010 Nov; 31(22):2741-8. PubMed ID: 20974801 [TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy. Victor VM; Apostolova N; Herance R; Hernandez-Mijares A; Rocha M Curr Med Chem; 2009; 16(35):4654-67. PubMed ID: 19903143 [TBL] [Abstract][Full Text] [Related]
13. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Münzel T; Sinning C; Post F; Warnholtz A; Schulz E Ann Med; 2008; 40(3):180-96. PubMed ID: 18382884 [TBL] [Abstract][Full Text] [Related]
14. Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Guzik TJ; Harrison DG Drug Discov Today; 2006 Jun; 11(11-12):524-33. PubMed ID: 16713904 [TBL] [Abstract][Full Text] [Related]
15. Clinical aspects of reactive oxygen and nitrogen species. Warnholtz A; Wendt M; August M; Münzel T Biochem Soc Symp; 2004; (71):121-33. PubMed ID: 15777017 [TBL] [Abstract][Full Text] [Related]